Next-Generation Assessment of ERBB2 (HumanEpidermal Growth Factor Receptor 2) Amplification Status

Dara S. Ross,* Ahmet Zehir,* Donavan T. Cheng,* Ryma Benayed,* Khedoudja Nafa,* Jaclyn F. Hechtman,* Yelena Y. Janjigian,y Britta Weigelt,* Pedram Razavi,y David M. Hyman,y José Baselga,y Michael F. Berger,* Marc Ladanyi,* and Maria E. Arcila* 89 90 91 From the Department of Pathology* and the Division of Solid Tumor Oncology, y Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 92 93 94 Accepted for publication